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In mouse follicular melanocytes, the switch between 
eUlDelanin and pheolDelanin synthesis is regulated by 
the exte1lsio1l locus, which encodes the melanocortin-l 
receptor (MC1R) and the agollti locus, which encodes 
a novel paracrine-signaling molecule that inhibits 
binding of melanocortins to the MC1R. Human lDe-
lanocytes express the MC1R and respond to mela-
notropins with increased proliferation and eumelano-
genesis, but a potential role for the human homolog of 
agouti-signaling protein, ASIP, in hU111an pigmenta-
tion has not been investigated. Here we report that 
ASIP blocked the binding of cx-melanocyte-stimulating 
hormone (cx-MSH) to the MC1R and inhibited the ef-
fects of cx-MSH on human melanocytes. Treatment of 
huma.n melanocytes with 1 1~-10 nM recoInbinant 
Inouse or human ASIP blocked the stitntdatory effects 
T h e switch to produ cc cumelanjn or pheom clanin in . m o use fo llicular m elanocytes IS controlled by the exlells;o// (e) and ago lll; (a) loci (Si lvers, 1958; Takeu-chi (!( ai, 1989). The form cr cncodes thc M C l receptor, the melanocortin receptor, which is ex-
pressed on m e lan ocytes (Tnmate and T akeuchi , 1984; Mo ungoy cl 
ai, 1992; R o bbim £'I (/1 , 1993; Suz uki e/ ai, 1996). The agoll!; locus 
codes fo r the agouti - signaling pro te in (ASIP) , an intl;nsic f., ctor 
cxpressed by de rmal papi ll a ce ll s within the mouse hair follicl c, 
w hich fun ctio ns as a paracrine regulator of mouse m elanocytes 
(Mill e r et ai , 1993) . Al though ASIP acts ;11 /' ;Im and ;11 /1;110 as an 
an tagonist of a-me lanocyte- stimulating hormonc (a -MSH) sign al-
ing m cdiated by the mouse m elanocortin-l receptor (M C IR) , its 
exact m echanism of ac tio n is sti ll controversial (Lu el ai , 1994; Yen 
cl ai, 1994; Blanchard d ai , 1995; Mannc d ai, 1995; Z emel el ai, 
1995). W e and o thers hav e recentl y demonstrated a mitogenic and 
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of cx-MSH on cAMP accumulation, tyrosinase activity, 
and cell proliferation. In the absence of exogenous 
cx-MSH, ASIP inhibited basal levels of tyrosinase activ-
ity and cell proliferation and reduced the level of 
inttnunoreactive tyrosinase-related ptotein-l (TRP-l) 
without significantly altering the level of inununoreac-
tive tyrosinase. In addition, ASIP blocked the stimula-
tory effects of forskolin or dibutyryl cAMP. agents that 
act downstreaIn from the MC1R, on tyrosinase activity 
and cell proliferation. These results deInonstrate that 
the functional relationship between the agouti and 
MC1R gene products is sitnilar in Inice and humans and 
suggest a potential physiologic role for ASIP in regula-
tion of human pigInentation. Key words: melarlOcortill-1 
receptor/melanogellesis/agouti locus/extension loclls. ] Illvest 
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m elanogenic response to a -MSH, f3-MSH, and ACTH by human 
me lanocytes in culture (De Luca et ai, 1993 ; Hunt ct ai, 1994a, 
1994b; Abdel-Malek el ai , 1995; Suzuki el ai , 1996) . Recently, it 
was reported that a -MSH increases the synthesis of eumelanin in 
these cells (Hunt ct ai, 1995). Additional support for the notion tllat 
the MCl R has homologous fun ctions in human and mouse pig-
mentation came from th e recent observation that human MC1R 
variants are asso ciated with fair skin nnd red hair (Valverde el aI, 
1995) . A hum an homolog for the mouse ago lit; locus has been 
cloned , and its produc t w as found to fun ction similarly to the 
mouse prote iJl ill /1;1,.0 and ;11 /I;"" (Kwon el ai, 1994 ; Wilson el aI, 
1995) but the response of human melanocytes co ASIP and its 
potential ro le in human pigmentation has not been investigated , 
Ectopic overcxpression of ASIP .in mice leads to obesity and 
in creased tumor susceptibility [reviewed by Siracusa (Siracusa, 
1994)J (Yen cl (/1, 1994) . It has been st.lggested that human ASIP 
m ay play a role in the regulation of these phenotypcs as well 
(Mann e ef ai, 1995). 
The human ASIP consists of132 am.ino acids and is 80% identical 
in amino acid se quence to its mouse homolog (Kwon el ai, 1994; 
Wilson el ai, 1995). W e havc been irivestigating the effects o f 
recombinant human and mouse ASIP and thcir inte raction with 
a -MSH on cu ltured human m elaJlocytes. H ere we report that ASIP 
competes with a -MSH for binding to the MCl R and that both 
m o use and human AS[)J inhibit basal and a -MSH-stimulated 
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tyrosinase activity and proliferation. Moreover, ASIP inhibits the 
activity of agents that mimic the effects of a -MSH and act 
downstream of the MC1R. The demonstration th at human mel a-
nocyi:es respond to ASIP is an important step toward understanding 
the possible physiologic efli:cts of this hormone and the mecha-
nisUl(s) by which it interacts with melanotropins to affect human 
melanocytes as well as other target cell s. 
MATERlALS AND METHODS 
Melanocyte Culture Conditions Primary cultures of normal hum'1I1 
melanocytes were established from neonatal foreskins representing different 
skin types as described previously (Abdc1-Malek of III, 1993). The complete 
growth medium used consisted of MCDB 153 supplemented with 4')'0 feta l 
bovine SCrUI11, 1 fLg illlll1an transferrin per 1111, 5 j.!g insuLin pe r 1111, 1 j..Lg 
a-tocopherol per ml , and the melanocyte mitogens human recombinant 
basic fibrob last growth factor (0.6 ng per ml). 12-0-tetradecanoylphorbol-
13-acetate (8 nM) (a ll purchased fr0111 Sigma Chemica l Co .. St. Louis, MO) , 
and bovine pituitary extract (13 J..Lg per ml) (Clonetics, San Diego, CAl, as 
previously described (Medrano and Nordlund, 1990). Sin'ce bovine pituit<lry 
extract contains high concentrations of a -MSH, we found it essential to 
remove it from the culture medium in order to assay the effects of 
exogel~ollS melanocortins (Abdel-Malek Of (//, 1995). 
Recombinant ASIP was purified from conditioned media of insect cells 
infected with a baculovirus const.ruct that contained t.he mouse or human 
cDNA (Wilson ef 11 /, 1995). The purification prot~co l wiIl be described 
el;ewhere (Ollmann and Barsh, in preparation) but in brief is based on ion 
exchange chromatography simi.lar to the protocols of Wilkison and col-
leagues (Lu ef (//. 1994; Blanchard ef (//, 1995). ASIl' activity during 
purification was monitored by its ability to inhibit a-MSH-induced pigment 
granule dispersion in frog melanophores. T he purity of recombinant ASIP. 
estirrtated at > 90%, was based on ana lys is by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis. 
Receptor Binding Assays: Competition of 125I_[Nle4,D_Phe']_a_ 
MSH Binding to MCIR by a -MSH or ASIP [Nle4 ,D-Phe']-a-MSH 
(NDP- a -MSH) (Sigma Chemical Co.), a potent and nonbiodegradab le 
synt.hetic analog of a-MSH (Marwan Cf (/ /, 1985; Suzuki of (//, 1996), was 
labe l e d with 1251 as fo llows. Twenty Ini c ro titc rs of 0.4 M sod iu1l1 acetate 
(pH 5 .6), 1.5 mCi 125,] (DuPont, NEN. Boston, MA). 4 J..Lg NDP-a-MSH , 
5 J..Ll of 0.1 J..Lg per ml lactoperoxidase, and 4 J..LI 30% H20 , were added and 
vortexed lightly for 45 s. The reaction was stopped by t',e addition of 300 
iLl 0.1 % acetic acid in phosphate-bulfered saline. Subsequently, 300 J..LI 
Dowex solution in 0.2 N acet.i c acid were added and, fo llowing centrifu-
ga tion, the supernatant was purified using G-25 colunUl pre-swollen in 0.2 
N acetic acid. Fractions were collected every 30 s. and the fractions with the 
highest radioactivity were utilized for receptor bin ding assays. 
Melanocytes were inoculated into 24- wcll plates at a dens ity of 4 X 105 
cellsh;yell and allowed to attach for 2 d. CeIls were then washed twice Witl1 
1 ml of MCDB 153 medium containing 0.5% bovine serum albumin 
(fraction V, Sigma Chemical Co.) and incubated in 0.5 ml of MC DB 
mediun1 containing 0.5% bovine se rum albumin. 0.3 mM l,lO-phenanth-
roline (proteinase inhibitor; Sigma Chemica l Co.) and 100,000-150,000 
cpm of [' 25 I]N DP-a-MSH (' 2S I[Nle4 ,D_Phe' _a _MSH]) and various con-
centrations of unlabe led a -M SH or human AS I!' at room temperature for 
2 h . After incubation, melanocytes were washed three t.i mes witll 1 ml of 
ice-cold MCDB medium containing 0.5'!!" bov ine seruIll albumin and lysed 
with 1 ml of 0.5 N NaO H , 0.4% deoxycholate. Radioactivity was counted 
in a ,,-counter and the data were analyzed by linear regression using 
software from Kaleidagraph. 
Deterttlination of Cellular Proliferation and Tyrosinase Activity 
Melanocytes maintained for 2- 4 d in mediulll devoid of bovine pituitary 
extract were plated in 12.5 cm2 flasks at a density of 1 X 105 cell s per fl ask. 
Forty- e ight hours later and every otller day thereafter for a tota l of 6 d, 
melanocytes were treated with 10 nM monse ASH' or 0.1 J..LM huonan AS]P 
in the presence or absence of 1 nM a-MSH , 0.1 J..LM forsko lin . or 10 J..LM 
dibutyryl (db) cAMP. Previously we reported that the response of human 
melanocytes to a -MSH is maximal fo llowing 4- 6 d of treatment (AbdeI-
Malek et (//, 1995). O n day 5 of treatment, each flask received 2.2 J..LCi 
r H]tyrosine (0.733 J..LCi per ml medium; Amersham, Arl ington Heights, 
IL). Sixteen to eighteen holll's later, cell s frolll each flask were ha.rvested and 
counted using a Coulter counter, and the tyrosine hydroxylase activity of 
tyrosinase was In casurcd i" situ using a 111oditi cation of the charcoa l 
absorption metl'lOd ofPomcrantz as described previously (Pomerantz, 1969; 
Abd e l-Malek Cf 11/, 1992). 
Cyclic AMP Assays M e h1110cytes were Inaintaincd in bovine pitlLitary 
extract-free growth medium for at least 2 d prior to and for the duration of 
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the experiments. Cells were pIa red onto 24-we.1l plates at a densiry of 3 X 
l0 5 cell s per well. ForC)'-cighr hours later ft'esh medium w as added to each 
well, and on the next day the cAMP assays were perfo nlled as follows. The 
growth 1l1cdiul11 was r enloved frO ll1 each well and replaced \.vith 450 J..I..I of 
growth medium containing 0.1 mM isobuC)'1 mcthylxantlline, a phospho-
diesterase inhibitor. T he cultures were incubated for 10 -20 min with thi s 
medium at 37°C and tllell trea ted with 10 nM or 0.1 f..tM u-MSH. 10 nM 
or 0.1 J..LM ASIp, or both for 45 min <1t 37°C in a tota l volume, in each well. 
brought up to 0.5 1111. The reaction was stopped by the add ition of 50 J..LI of 
1 N HC I. Duplicate 250-J..LI samples were removed, and 750 J..LI of 0.1 N 
H C I were added . Each sample was then aceC),lated by the addit.ion of 40 J..LI 
of triethylamine and acetic anhyd ride (2 .5:.1 vol/vol) . and the amount of 
cAMP was determined by radiolllllllunoassay as previollsly described by 
Liggett ef II/ (1989). 
Western Blot Analysis of Tyrosinase and Tyrosinase-Related Pro-
tein t (TRP-l) Cells were treated with 10 nM mouse AS IP in the 
presence or absence of 1 nM a -MSH fo r a total of 6 d, as described above. 
Cell Iysates were prepared using IUPA buffer (Sambrook cf (// , 1989) 
containing the phospha tase inhibitor Na,) VO., (10 mM) and protease 
inhibitors onethylsulfonyl flu oride (200 111M) , aprotinin (10 J..Lg per ml), and 
leupeptin (10 J..Lg per ml) . Equal amounts of protein (5- 8 J..Lg) were loaded 
on each lane and separated on a 7.5% polyacrylamide gel by electrophoresis. 
Follo\>ving transblotting onto nitrocellulose nlcnlbran cs, th e 111 Cnlbran es 
were incubated with a hPEP-7 (1: 1500) , a polydonal antibody ra ised against 
the carboxy tenninus of hUlllan C)'rosinasc (a gift frolll Dr. Richard King, 
University of Minnesota) , or with TA99 (1:1500), a monse monoclonal 
antibody raised aga inst human T IU'-l (kindly provided by Dr. Setalllri 
Vijayasarad hi, Rockefeller UniversiC)' . New York, NY). T he membranes 
were then incubated with horseradish peroxidase- conjugated anti-rabbit 
IgG (Amcrshal1l; 1:3000 dilu tion) followin g incubation with a hPEP-7, or 
with anti-mouse IgG (Amersham ; l :15 ,000 dilution) following incubation 
with TA99. T he immunoreactive bands were detected b), chemilumines-
cence, using the Renaissance Kit (Dupont, NEN , Boston, MA). Under 
these conditions, a hPEP- 7 recognizes inlnlunorc active 111:ltc riaJ inl ys~ltes of 
normal or TR .. P-l-negative albino melanocytes, bllt not in Iysates of 
tyrosinase-negative albino tncl anocytcs that la ck expression of ty rosinase 
(Boissy RE, Abdel-Malek Z A. Oetting WS . H earing VJ, and King RA: 
111anuscl·ipt in preparation). 
RESULTS 
Antagonism of the Effects of a-MSH on Human Melano-
cytes by ASIP Recombinant mouse ASIP inhibits the binding of 
radio labele d NDP-O'-MSH to m ouse melanoma cell s (Blanch ard et 
ai, 1995) or h eterologous cell s th at express the mouse M Cl R (Lu 
ef ai , 1994). To deterJ1'line whether human AS lP would act in a 
similar manner, we m easured the binding of [' 2' l]NDP-MSH to 
intact human m e lanocytes in the pre sen ce of in creasing concentra-
tions of human ASIP or a -MSH (Fig 1). T h e lCso valu es of ASIP 
and a -MSH were 3.128 = 0 .13 nM (mean = SEM) and 1.71 = 
0.56 nM , respectively, which su ggests that th e sh ort-term action of 
human ASIP on human melanocytes is similar to t.be action of 
mouse ASTP o n their mouse counterpnrts. 
We n e xt examine d th e lon g-term fun c tio n al con seq uences of 
ASIP o n human m e lanocyte s. Melanocyte lines det·ived from 
individuals of dilferent pigmentary phe n otypes express diffe re nt 
basa l tyrosinase activitie s and may vary in the e xtent of their 
respon se to a-MSH (Abdel-Malek ef al. 1993; Hunt ef ai , 1994a ; 
Abdel-Malek el ai , 1995). We have shown previously, h owever, 
th at 1 nM a -MSH elicits a n ea t·-maximal stimulation of prolife ra-
tion and tyrosinase ac tivity in human m e lanocyte lines d e rive d liom 
d o nors with different pigmentary p h enotypes after a 6-d trea tme nt 
pe riod (Abdel-Male k ef nl, 1995 ; Suz uki ei ai , 1996). In three 
separate exp e riments carri ed out with different melanocyte lines, 
complete abrogation of these effects was observed upon addition o f 
10 nM mouse o r (U JLM human AS1P. R epresentative data tiom 
two experiments are shown in Fig 2 where, in Experim ent 1, 1 nM 
a -MSH caused a 70% increase in cell prolife ratio n and a 140% 
increase in tyrosinase activity, and 10 nM m OllSe ASIP re duced both 
e ffec ts to con tro ls levels. In Fig 2, Experiment 11, using anothe r 
m elanocyte line, 1 nM a -MSH caused an approximate ly 75% 
increase in proli feration and a 62'10 in crease in tyrosinase activi ty. 
Again, both effects were abolished in the p resen ce of O. J JLM 
human ASIP . Treatment with 10 rtM mouse o r 0.1 JLM human 
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Figure 1. Displacement of [. 25I)NDP-a-MSH binding to the MC1R 
by increasing concentrations of human ASIP or a -MSH. Melano-
cytes were incubated in the prescnce of 100.000 -1 50,000 cpm of 1. 25 1]_ 
NDP-MSH alonc (for total binding) or in the prescnce of increasing 
concentrations (10- 11 _10 - (' M) ofa-MSH or human ASlP for 2 h at room 
temperaturc. as described in Materials and Metholls. T he amount of radioac-
tiv ity was counted in a y-counter, and the data were ana lyzcd by Kaleida-
grapb software. Each va lue represents the mean coun ts per minute of three 
dcterminations ::':: SEM . Maximal binding was obtained in the absence of 
any cold ligand . T illS experimcnt was repeated twice with similar findings 
using two different melanocyte lines. 
ASlP alone reduced basal tyrosinase actiVIty by 50% and 13%, 
respectively, and also had a small but significant inhibitory e ffect on 
ceU proliferation. 
Modulation of Expression of Tyrosinase and TRP-l by ASIP 
In mouse melanocytes , the effects of a-MSH and ASIP o n tyrosi-
nase activity are m ediated primarily at the level of mRNA (Sakai el 
aI, 1997). To in vestigate the level at which ASIP inhibited tyros i-
n ase a.ctivity in human melanocytes, we carried out western hlot 
an<!lysis of cell s treated with AS!P and /or a-MSH using an antibody 
(a hPEP- 7) that detects aU tyrosinase isozymes . T he level of tyrosi-
nase protein rem aine d constant a fter exposure to either 1 nM 
a -MSH o r 10 nM ASIP, suggesting that the effects of ASIP on 
tyrosinase activi ty are p osttranslational or are m ediated by the 
activa ti o n of a tyrosin ase inhibitor (Fig 3) . In terestingly, the level of 
TKP-l (detected by TA99 antibody) , which was increased by 1 nM 
Figure 2. Inhibition of human melanocyte 
proliferation and tyrosinase activity by 
mouse (Experiment I) and human (Experi-
ment II) ASIP, in the presence or absence of 
a -MSH. Melanocytes were treated 48 h after 
plating and every other day thereafter fo r a total of 
three treatltlents fo r 6 d with 10 nM mouse AS IP, 
or 0.1 fLM human ASIP, in the presence or 
absence of 1 nM a-MSH. Forty-eight hours after 
the final treatment, cell llull1bcrs and tyrosinase 
activities w ere d etermi.n e d. The e xpcrinl cnts pre-
sented were repeated three times lI sing different 
tncl anocytc Lines each bnle, w-ith similar findin gs. 
* Indicates that the difference between the ex per-
ilTIcnta l and con trol groups is statisticall y signifi-
cant at p :s 0.001. ** Denotes that the experimen-
tal and contro l groups are signi fica ntly different at 
p = 0.07, as determined by unpaired Student' s t 
test. 
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Figure 3. Inhibition of TRP-l but not tyrosinase levels following 
treatment with mouse ASlP, in the absence or presence of a -MSH. 
Melanocytes were treated with 10 nM mouse ASIP with or without 1 nM 
a-MSH as described for Fig 2, and ce ll Iysates were prepared 48 h after the 
final treatment. Proteins were separated by c1.ectrophoresis using 7.5% 
polyacrylalnjdc gels, and western blotting ana lysis for tyrosinase (A) and 
T IU>-l (13) was performed using a hl
'
EP-7 polycloua l antibody and TA99 
l110use 1110nociollal antibod y, respecti vely. T h e il111'111l110rcactivc b~Ulds were 
detected using chemjluminescencc. Lanes 1-4 reprcsen t control , ASIP, 
a -MSH. and AS!P + a -MSH, respectively. T his experiment was repeated 
three tinlcs with sirnilar resul ts. 
a -MSH, was signi.fi cantly reduced in response to addition ofl0 uM 
ASIP (Fig 3) . N o rth ern blot ana lysis of tyrosinase, TRP-1 , and 
TRP-2 re vealed no change in the steady state mRNA levels of 
these enzymes following treatment for 4 d w ith ASIP o r ASIP and 
a -MSH (data not shown) . T hese results suggest that the inhibitory 
e ffect of ASIP on m e lanogenesis in human m e lanocytes is not 
elicited at the transcriptional level. 
Inhibition of a-MSH- Induced cAMP Formation by ASIP 
Blanchard et al (1995) have shown previously that trea tment of 
mouse B16F10 melanoma cells with recombinant agouti protein 
d oes not significan tly alter basa l levels of cA MP production. In 
con trast, no[mal mouse m e lanocytes t reated w ith ASIP in the 
absence of exogenous a -MSH exhibi ted a small but significant 
decrease in cAMP accumulation (Sakai e/ nl, 1997) . W e found tha t 
treatment of human m e lanocytes with 10 nM or 0.1 J.LM mouse 
AS !P did not significantly affect the basa l level of cAMP accumu-
lation (Fig. 4) . When mouse ASIP and a-MSH were added 
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Figure 4. Downregulation of basal and a -MSH- induced cAMP 
levels by mouse ASIP. Melanocytes were incubated for 45 min with 10 
nM or 0 .1 fLM mouse ASIP in the presence or absence of 1 0 11M or 0.1 fLM 
a-MSH, in a medium containing 0.1 mM isobutyl methylxanthine. Cyclic 
AMP levels WCrc determined by radioimmunoassay. SinUJar results were 
obtained in fou r independent experiments. 
together, however, ASIP caused a dose-dependent inhibition of the 
a-MSH induced cAMP accumulation (Fig 4). Treatment of mela-
nocytes w ith 10 nM or 0 .1 /-tM a - MSH resulted in a 7- or 8.5- fold 
increase in cAMP, respectively. Concomitant treatment with 1 nM 
mouse ASIP reduced the effects ofl0 or O.l/-tM a-MSH by 80% or 
43%, respectively. Similarly, treatment with 0.1 /-tM mouse ASIP 
diminished the above effects of a - MSH by 83% or 58%, respec-
tively_ 
Abrogation of the Mitogenic and Melanogenic Effects o f 
Forskolin and dbcAMP by ASIP The effec ts of ASIP on 
nonnal human m elanocytes were evident in the presence as well as 
in the absence of exogenous a -MSH_ To further investigate the 
effects of ASIP in the absence of a - MSH, we determined whether 
ASIP could inhibit the forskolin- or dbcAMP- induced melanocyte 
proliferation and tyrosinase stimulation (Fig 5)_ We found that 0 .1 
JLM forskolin or 10 /-tM dbcAMP stimulated melanocyte prolifer-
ation by 82% or 52%, respectively, and increased tyrosinase activity 
by 300/0_ These effects were completely inhibited by 10 nM mouse 
ASIP, and tyrosinase activity was reduced even below cOlltrol 
valu es _ These results confirm the ability of ASIP to affect hurnan 
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melanocytes by antagonizing the cAMP-dependent signaling path-
way_ 
DISCUSSION 
The genetics of monse coat color have provided great insights into 
the biochemical control of melanogenesis and the interac tion 
be tween different gene products. In many cases, the products of 
human pigmentation genes have been ShOWl1 to carry out functions 
similar to those of th eir mouse homologs ill lIitm and in lIillo . 
Whether the products of the human and mouse extellsion (MGt R) 
and agouti (A ) loci have functions similar to their mouse counter-
parts is not yet resolved_ 
In mice, activation of the MC1R promotes eumelanin synthesis, 
whereas mutations that inactivate the MC1R gene result in 
pheomelanin formation . Expression of the agouti prote in induces a 
switch from eumelanin to pheomelanin fonnation (Silvers , 1958) _ 
T his e ffect appears to be mediated , in part, by the ability of ASIP to 
act as an inhibitor ofa-MSH binding to the MC1R (Lu et ai, 1994; 
Blanchard et aI, 1995 ; Siegrist et aI, 1996) _ Other studies (Yen et ai , 
1994; HWlt and Thody, 1995; Zemel et aI, 1995; Sakai et aI, 1997) 
have suggested, however, that agouti protein may act via a receptor 
distinc t from the m elanocortin receptors_ In addition, the human 
homolog of agollti, ASIP, is normally expressed in nonpigmented 
tissues including the heart, gonads, and adipose tissu e (Kwon et aI, 
1994; Wilson et ai, 1995) , and it has been suggested that ASIP may 
play a role in nonnal regulation of celJular processes other than 
pigmentation (Manne et aI , 1995) _ It was demonstrated recently that 
ASIP is an antagonist for the MC4R, which accounts for the obesity 
associated with ectopic expression of ago",ti prote in in AY and A vy 
mice (Lu et aI, 1994; Yen et aI, 1994; Fan et aI, 1997). 
Here we report that n0n11al epidermal human melanocytes 
treated with recombinant mouse or human ASIP exhibit physio-
logic effects predicted by the genetics of mouse coat color. These 
effects can be attributed to a large exten t to the ability of ASIP to 
inhibit binding of a -MSH to the MC1R (Fig 1). Both the human 
and mouse proteins block the capacity of a - MSH to stimulate 
mitogenesis and m elanogenesis, although in long-term assays ·the 
mouse protein is apprm . 'imately 10- fold more potent than the 
human protein (Fig 2). This difference is not due to experimental 
variation in the donor m elanocytes or the preparation of agouti 
protein, inasmuch as it was observed in several independent 
experiments with various con centrations of ASIP and multiple 
donor melanocytes _ In addition, these identical preparations of 
human or mouse ASIP have been tested for their capacity to inhibit 
a-MSH binding to heterologous cells that eX1'ress the mouse and 
h uman MCIR and exhibit similar KD values (Yang and Gantz, 
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Figure 5. Abrogation of the forskolin 
and dbcAMP induced melanocyte pro-
liferation and tyrosinase activity by 
ASIP. Melanocytes were treated every 
other day for a total of 6 d with 0.1 fLM 
forskoLin , 10 fLM dbcAMP, or 1 I~M a-MSH 
in the presence or absence of 10 nM tnouse 
ASIP, as described in the legend for Fig 2. 
Cell numbers and tyrosinase activities were 
determined 48 h after the final treatment. 
This experiment was repeated twice with 
similar results. * Indicates that the difference 
between the experimental and control 
groups is statisticaIly significant (p :s 0.001) 
as detenruned by unpaired Student's t tesc 
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unpublished data ) . AS IP was a m ore potent inhibitor of T RP-l than 
tyrosin ase in human melanocytes, an effec t that appears to be 
impo rtan t fo r the switch from eumelanin to pheom elanin synth esis 
(Saka i ct (I I, 1997) . Whether ASH) fun ctions as a positive effec tor of 
pheom elanin synthesis or only m odula tes the effec ts of a -MSH by 
blockin g its sign aling path way is currently being investigated. Th e 
abili ty of AS IP to increase pheom elanin synthesis may h ave impor-
tan t implica ti ons on the response o f melanocytes to ultravio let light 
and 0 11 the photoprotective ro lc of cpidcLlnal me lanin , particularly 
beca use p heomelanin is m ore susceptible to ph otodegradatio n than 
eumelanin (C hedeke\ ct ai , 1978; M eno n el (II , 1985). 
Several possibilities have been prop osed to explain ASIP ac tion , 
in cluding competitive in hibi tion of melanocortin bindin g and stim-
ulation ofa putative " agou ti rccep to r" (Yen e/ ai, 1994; Blanchard 
el ai, 1995; H un t and T ho dy, 1995 ; M anne el nl, 1995) . W e fo und 
tha t, in general, ASIP antagonizes the e ffects of a -MSH and inhibi ts 
[' 2sl]NDP-a -MSH binding. W e also fo und that ASIP could inhibi t 
the stimul ati o J] of tyrosimlse activity and cell pro liferation in the 
absence of exogenous a-M SH and in response to agents su ch as 
fo rskolin and dbcAMP tha t act downstream of the M C l R . T hese 
results could be expl ained by in verse agonism o r an e ffec t of ASIP 
o n MCIR desensitization . Alte rnative ly, ASJP may al so bind a 
receptor distinct frO I11 MCIR th at antagonizes the signalin g path-
w ay mediated by cA MP. T h is putative recepto r is ye t to be 
identifi ed. 
Rega rd less of the precise biochemical mechanism(s) by which 
ASJP ac ts, o ur observations have implica tions fo r understandin g the 
facto rs tha t control norm al human p igmentation . R ecent studies 
byf Valverde e/ a/ (1 995) dem onstrated an increased frequency of 
ce rtain M C t R sequence variants among Caucasian individuals with 
red hair and fair skin . O ur results provide fUll cti onal evidence to 
suppo rt the idea tha t M C l R sign aling affec ts the behavior o f human 
melanocytes and sugges t tha t genetic v aria tion in ASIP might also 
influence human pi gmenta tion. 
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